NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
China Aoxing Pharmaceutical Company, Inc. »14/04/2010 [Company watch]
China Aoxing Pharmaceutical Corp. Approved to List on NYSE AMEX

Aoxing Pharmaceutical Company, Inc, a specialty pharmaceutical company focusing on research, development, manufacturing and distribution of narcotic and pain-management products, today announced that it received authorisation to list its common stock on the NYSE AMEX market.

 
Aoxing Pharmaceutical Company, Inc, a specialty pharmaceutical company focusing on research, development, manufacturing and distribution of narcotic and pain-management products, today announced that it received authorisation to list its common stock on the NYSE AMEX market. Aoxing Pharma expects to begin trading on NYSE AMEX, a subsidiary of NYSE Euronext, on Wednesday, April 14, 2010 under the ticker \"AXN,\" until which time its common stock will continue to trade on the Over the Counter Bulletin Board under the symbol \"CAXGD.\" \"We are excited to report that our application to list on NYSE AMEX has been approved,\" said Mr. Zhenjiang Yue, chairman and CEO of Aoxing Pharma. \"This is a very important milestone for our company and shareholders. Being listed on NYSE AMEX provides us with greater visibility for our company, more liquidity for our stock and the opportunity to further expand our investor base. Furthermore, it enhances our corporate image to our industrial peers as our drug industry is international by nature and we continue striking on global business collaboration and market expansion. I believe that this move will deliver increased value for our shareholders now and down the road.\"

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.